Poland· PL-100491548
Lentulil
A lenvatinib product containing lenvatinibum, registered in Poland by Egis Pharmaceuticals PLC. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Lenvatinib is registered in 15 of 19 countries.
Countries holding a registration under ATC L01EX08 (lenvatinib), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Lenvatinib · ATC L01EX08
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lenvatinib costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lenvatinib · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$297.39
The record
At a glance
URPL (Poland)- Active substance
- Lenvatinibum
- Manufacturer
- Egis Pharmaceuticals PLC
- Country
- Poland (PL)
- ATC code
- L01EX08
- ATC class
- Lenvatinib
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05995327203843
- gtin05995327203850
- gtin05995327203867
- gtin05995327203874
- gtin05995327203881
- gtin05995327203898
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
315 interactions on record for lenvatinib.
Graded by severity as the source publishes them — 81 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lenvatinib · interactions on record
315 records
- 81 severe
- 230 moderate
- 4 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lenvatinib in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaKISPLYXEisai GmbH, Frankfurt am Main
- NetherlandsKisplyx 4 mg, harde capsuleEisai GmbH
- FinlandIxedafinSTADA Arzneimittel AG
- SwedenKisplyx 4 mg Kapsel, hårdEisai GmbH
- United StatesLenvimaEisai Inc.
- SpainKISPLYX 4 MG CAPSULAS DURASEisai Gmbh
- BelgiumIxedafin 4 mgStada Arzneimittel
- IrelandKisplyx 4 mg hard capsulesEisai GmbH
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Lenvatinib Accord, Lenvatinib Rcc Sandoz
- Belgium · Ixedafin, Lenvatinib Accord
- Bulgaria · Ленватиниб Виатрис
- Cyprus · Lenvatinib Remedica
- Czechia · Lenvatinib Accord, Lenvatinib Sandoz
- Germany · Lenvatinib Accord, Lenvatinib Hexal
- Denmark · Lenvatinib Accord, Lenvatinib Sandoz
- Estonia · Lenvatinib Remedica, Lenvatinib Sandoz
- Spain · Lenvatinib Accord, Lenvatinib Sandoz
- Finland · Ixedafin, Lenvatinib
- France · Lenvatinib Accord, Lenvatinib Biogaran
- United Kingdom (Northern Ireland) · Lenvatinib, Lenvatinib Thornton & Ross
- Greece · Kynvalib, Lenvatinib Elpen
- Croatia · Lenvatinib Remedica
- Hungary · Lenvatinib Stada
- Ireland · Lenvatinib Accord, Lenvatinib Stada
- Iceland · Kisplyx, Lenvima
- Italy · Lenvatinib Accord, Lenvatinib Sandoz
- Liechtenstein · Kisplyx, Lenvima
- Lithuania · Lenvatinib Sandoz, Lenvatinib Stada
- Luxembourg · Ixedafin, Lenvatinib Olpha
- Latvia · Lenvatinib Sandoz, Lenvatinib Stada
- Malta · Lenvatinib Remedica, Lenvatinib Stada
- Netherlands · Lenvatinib 1a Pharma, Lenvatinib Accord
- Norway · Kisplyx, Lenvatinib Accord
- Portugal · Lenvatinib Accord, Lenvatinib Sandoz
- Sweden · Lenvatinib Accord, Lenvatinib Avansor
- Slovenia · 10 Mg, Lenvatinib Sandoz
- Slovakia · Lenvatinib Pharmevid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b8a53d91-c230-47d6-9a19-b9c053db405c GET /v1/drugs/b8a53d91-c230-47d6-9a19-b9c053db405c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "4 mg",
"packaging": "05995327203843 ¦ Rpz ¦ 163656\n30 kaps. w blistrze\n05995327203850 ¦ Rpz ¦ 163657\n60 kaps. w blistrze\n05995327203867 ¦ Rpz ¦ 163658\n90 kaps. w blistrze\n05995327203874 ¦ Rpz ¦ 163659\n30 kaps. w blistrze perforowanym\n05995327203881 ¦ Rpz ¦ 163660\n60 kaps. w blistrze perforowanym\n05995327203898 ¦ Rpz ¦ 163661\n90 kaps. w blistrze perforowanym",
"substance": "Lenvatinibum 4 mg",
"common_name": "Lenvatinibum",
"pl_product_id": "100491548",
"pozwolenie_nr": "29409",
"auth_procedure": "DCP",
"authorisation_validity": "2030-12-01"
}See everything about lenvatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.